Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo

OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone

(2015) Penelope D. Ottewell et al.   INTERNATIONAL JOURNAL OF CANCER

Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion

(2015) Eva Rietkötter et al.   Oncotarget

Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis

(2014) Marie-Therese Haider et al.   BONE

Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo

(2014) P. D. Ottewell et al.   CLINICAL CANCER RESEARCH

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

(2014) Robert Coleman et al.   LANCET ONCOLOGY

Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer

(2013) X. H.- F. Zhang et al.   CLINICAL CANCER RESEARCH

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

(2012) R. Coleman et al.   ANNALS OF ONCOLOGY

Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid

(2012) P.G. Dedes et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Mouse models of breast cancer metastasis to bone

(2012) Kelsi L. Kretschmann et al.   CANCER AND METASTASIS REVIEWS

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid

(2012) Toni Ibrahim et al.   Cancer Cell International

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells

(2012) Lavinia Insalaco et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice

(2011) Penelope D. Ottewell et al.   BREAST CANCER RESEARCH AND TREATMENT

Direct antitumour activity of zoledronic acid: preclinical and clinical data

(2011) Joaquim Bosch-Barrera et al.   Clinical & Translational Oncology

The backbone of progress – preclinical studies and innovations with zoledronic acid

(2011) Jonathan R. Green et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

(2011) Robert E. Coleman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Local regulation of human breast xenograft models

(2010) Jodie M. Fleming et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Update on Estrogens and the Skeleton

(2010) Sundeep Khosla   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth

(2009) Hannu Mönkkönen et al.   ANTI-CANCER DRUGS

Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

(2009) H. Brown et al.   CURRENT CANCER DRUG TARGETS

Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

(2009) Penelope D. Ottewell et al.   INTERNATIONAL JOURNAL OF CANCER

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

(2009) Michael Gnant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo

(2008) P. D. Ottewell et al.   CLINICAL CANCER RESEARCH

Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer

(2008) P. D. Ottewell et al.   JNCI-Journal of the National Cancer Institute